Saltar al contenido
Merck

Hematogenous macrophage depletion reduces the fibrotic scar and increases axonal growth after spinal cord injury.

Neurobiology of disease (2014-12-03)
Y Zhu, C Soderblom, V Krishnan, J Ashbaugh, J R Bethea, J K Lee
RESUMEN

Spinal cord injury (SCI) leads to formation of a fibrotic scar that is inhibitory to axon regeneration. Recent evidence indicates that the fibrotic scar is formed by perivascular fibroblasts, but the mechanism by which they are recruited to the injury site is unknown. Using bone marrow transplantation in mouse model of spinal cord injury, we show that fibroblasts in the fibrotic scar are associated with hematogenous macrophages rather than microglia, which are limited to the surrounding astroglial scar. Depletion of hematogenous macrophages results in reduced fibroblast density and basal lamina formation that is associated with increased axonal growth in the fibrotic scar. Cytokine gene expression analysis after macrophage depletion indicates that decreased Tnfsf8, Tnfsf13 (tumor necrosis factor superfamily members) and increased BMP1-7 (bone morphogenetic proteins) expression may serve as anti-fibrotic mechanisms. Our study demonstrates that hematogenous macrophages are necessary for fibrotic scar formation and macrophage depletion results in changes in multiple cytokines that make the injury site less fibrotic and more conducive to axonal growth.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Dimetilsulfóxido, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Tetrahidrofuran, inhibitor-free, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Dimetilsulfóxido, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimetilsulfóxido, Molecular Biology
Sigma-Aldrich
Dimetilsulfóxido, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimetilsulfóxido, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Dimetilsulfóxido, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Tetrahidrofuran, contains 200-400 ppm BHT as inhibitor, ACS reagent, ≥99.0%
Sigma-Aldrich
Tetrahidrofuran, anhydrous, ≥99.9%, inhibitor-free
Sigma-Aldrich
Dimetilsulfóxido, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Alcohol bencílico, ReagentPlus®, ≥99%
Sigma-Aldrich
Alcohol bencílico, ACS reagent, ≥99.0%
Supelco
Alcohol bencílico, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Anti-laminina antibody produced in rabbit, 0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Dimetilsulfóxido, BioUltra, Molecular Biology, ≥99.5% (GC)
USP
Alcohol bencílico, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Dimetilsulfóxido, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
Alcohol bencílico, anhydrous, 99.8%
Sigma-Aldrich
Tetrahidrofuran, ACS reagent, ≥99.0%, contains 200-400 ppm BHT as inhibitor
Sigma-Aldrich
Dimetilsulfóxido, PCR Reagent
Sigma-Aldrich
Alcohol bencílico, puriss. p.a., ACS reagent, ≥99.0% (GC)
Sigma-Aldrich
Benzyl benzoate, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Alcohol bencílico, ≥99%, FCC, FG
Supelco
Alcohol bencílico, analytical standard
Sigma-Aldrich
Benzyl benzoate, ≥99%, FCC, FG
Sigma-Aldrich
Xylazine, ≥99%
Supelco
Tetrahidrofuran, analytical standard
Supelco
Dimetilsulfóxido, analytical standard
Supelco
Tetrahidrofuran, Pharmaceutical Secondary Standard; Certified Reference Material